Arvaya Healthcare Annual General Meeting
Arvaya Healthcare Limited held its 41st Annual General Meeting on 21st September 2026, where members adopted financial statements and approved material related party transactions.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
11 announcements with these filters
Arvaya Healthcare Limited held its 41st Annual General Meeting on 21st September 2026, where members adopted financial statements and approved material related party transactions.
Arvaya Healthcare has incorporated a wholly-owned subsidiary, Arvaya Insurance Broking Private Limited, for an investment of ₹0.80 Crore. This entity will provide insurance broking services.
Arvaya Healthcare Limited has dispatched web links to shareholders for accessing the Notice of its 41st Annual General Meeting and the Annual Report.
Arvaya Healthcare filed its 41st Annual Report for FY 2025-26, including the notice for the Annual General Meeting scheduled on 21 September 2026.
Arvaya Healthcare Limited issued a Notice of its 41st Annual General Meeting to be held on 21 September 2026 via video conferencing. The agenda includes approval for material related party transactions.
Arvaya Healthcare Limited approved the acquisition of a Copyright and Intellectual Property portfolio from Defib Institute of Health Solutions LLP for a consideration of ₹10 Crores.
Arvaya Healthcare Limited scheduled a board meeting for August 26, 2026, to discuss a related party transaction regarding the acquisition of a business undertaking.
Arvaya Healthcare Limited submitted the voting results and the Scrutinizer's Report for its recent Postal Ballot. The company confirmed that all 6 resolutions were successfully passed.
Arvaya Healthcare Limited plans to incorporate a new wholly-owned subsidiary to operate in the insurance broking service sector. The company will hold 100% equity stake.
Arvaya Healthcare Limited has informed the exchange that the Statement of Deviation or Variation under Regulation 32 is not applicable for the quarter ended June 2026.
Arvaya Healthcare Ltd reported revenue from operations of ₹29.9 Cr and net profit of ₹0.5 Cr for Q1 FY27.